Contraception in cancer survivors - an expert review Part I. Breast and gynaecological cancers.

Abstract

Objective: The efficacy of treatment for many cancers has increased dramatically in recent decades and there are a growing number of cancer survivors who need effective contraception. In this paper, a group of experts from the European Society of Contraception set out to define the most frequent cancers in women and summarise the guidelines, reviews and studies that provide information and guidance on contraception for each cancer. Methods: Epidemiological studies were analysed to determine the frequency of cancers in women of reproductive age. A narrative review was performed for each cancer, collecting data about the treatment of the disease, its impact on fertility, and the efficacy, health risks, possible benefits and contraindications of the contraceptive methods available. The recommendations were then summarised. Results: Owing to a large amount of information, the results are presented in two parts. Part 1 includes contraception after breast and gynaecological cancers. Part 2 summarises the findings and recommendations regarding contraception in women with skin, gastrointestinal, haematological and endocrine cancers.

• Authors: Anne Gompel, Isabel Ramirez, Johannes Bitzer, European Society of Contraception Expert Group on Hormonal Contraception
• Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (Eur J Contracept Reprod Health Care) Vol. 24 Issue 3 Pg. 167-174 (Jun 2019) ISSN: 1473-0782 [Electronic] England
• PMID: 31033361 (Publication Type: Journal Article, Review)

Chemical References

• Contraceptive Agents, Hormonal

Topics

• Breast Neoplasms (epidemiology, therapy)
• Cancer Survivors
• Contraception (adverse effects, methods)
• Contraceptive Agents, Hormonal (therapeutic use)
• Female
• Fertility
• Genital Neoplasms, Female (epidemiology, therapy)
• Humans
• Practice Guidelines as Topic
• Risk Factors